Trial for Bayer's Xarelto under scrutiny over defective device

BERLIN (Reuters) - European and U.S. drug safety agencies are looking into whether a defective blood-clotting test device affected a trial involving Bayer's anti-blood clotting drug Xarelto, they said on Tuesday.

http://ift.tt/1jMyJPg

from Reuters: Health News
via animenewspro